In case you missed them, here are the highlights of last weeks’ news:
Mexico holds the dubious honor of occupying the first place in diabetes in all OECD countries.
Pneumonia costs Mexico MX$77 million per year.
OECD warns of lags in Mexican public healthcare.
FDA offers warning on stem cell therapies.
Tuesday, Nov. 14, was the World Diabetes Day.
Researchers develop new strategy for treating cancer by controlling chromatin.
FDA approved Abilify MyCite, a pill that can track and inform a doctor when the patient took it, for the treatment of schizophrenia.